So, it has been observed that in patients with MG the CD19+CD5+CD1d+ Bregs are not only reduced in number as well as reductions in function by decreasing in cytokine production, e.g., IL-10 and TGF-β1. The gene discussed is CD1D; the disease is myasthenia gravis.